PRI, LLC - Los Alamitos - M3 Wake Research — Los Alamitos, California

PRI, LLC - Los Alamitos - M3 Wake Research is a clinical research site located in Los Alamitos, California, United States 90720.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

PRI, LLC - Los Alamitos - M3 Wake Research has participated in 1 clinical trials.

Therapeutic areas: Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations.

Sponsors: Rhythm Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Alamitos

Browse all research sites in California · View every site in Los Alamitos

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PRI, LLC - Los Alamitos - M3 Wake Research?

PRI, LLC - Los Alamitos - M3 Wake Research has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PRI, LLC - Los Alamitos - M3 Wake Research conducted?

PRI, LLC - Los Alamitos - M3 Wake Research has 1 clinical trials on record. Their work covers Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations.

Is PRI, LLC - Los Alamitos - M3 Wake Research accredited by Crixeo Clinical Trials?

PRI, LLC - Los Alamitos - M3 Wake Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PRI, LLC - Los Alamitos - M3 Wake Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.